HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
kryptopyrrole
metabolite in schizophrenia
Also Known As:
2,4-dimethyl-3-ethylpyrrole
Networked:
9
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Pyrroles: 369
kryptopyrrole: 9
Related Diseases
1.
Hepatic Porphyrias (Hepatic Porphyria)
05/01/1976 - "
The porphyrinogenic effects of kryptopyrrole in the rat and the occurrence of urinary kryptopyrrole in human hereditary hepatic porphyria.
"
05/01/1976 - "
2. Kryptopyrrole was present in the urine of patients with hereditary hepatic porphyria, in attack and in remission, but not in those with latent porphyria.
"
01/01/1979 - "
The concentration of kryptopyrrole required for 50% inhibition of a maximum twitch tension (ID50) was 0.085 mM. 3 Oxidation products of kryptopyrrole with chromatographic properties similar to those of urinary constituents reported in schizophrenia and hepatic porphyrias had little or no effect at similar concentrations.
"
2.
Porphyrias (Porphyria)
05/01/1976 - "
2. Kryptopyrrole was present in the urine of patients with hereditary hepatic porphyria, in attack and in remission, but not in those with latent porphyria.
"
3.
Acute Intermittent Porphyria (Porphyria, Acute)
12/02/1972 - "
Kryptopyrrole-like substance in acute intermittent porphyria.
"
02/01/1978 - "
No hemopyrrole or kryptopyrrole could be detected in 52 samples, from 17 controls, 29 schizophrenics, and six persons with acute intermittent porphyria.
"
4.
Schizophrenia (Dementia Praecox)
01/01/1979 - "
The concentration of kryptopyrrole required for 50% inhibition of a maximum twitch tension (ID50) was 0.085 mM. 3 Oxidation products of kryptopyrrole with chromatographic properties similar to those of urinary constituents reported in schizophrenia and hepatic porphyrias had little or no effect at similar concentrations.
"
01/01/1973 - "
Biochemical relationship between kryptopyrrole (mauve factor and trans-3-methyl-2-hexenoic acid (schizophrenia odor).
"
5.
Psychotic Disorders (Schizoaffective Disorder)
03/01/1975 - "
Kryptopyrrole causes major central nervous system dysfunction, and these findings are discussed in the context of a drug-induced model of psychoses.
"
11/22/1969 - "
Identification of kryptopyrrole in human urine and its relation to psychosis.
"
Related Drugs and Biologics
1.
Vitamins
2.
Acids
3.
2-hydroxyhemopyrroline-5-one
4.
hemopyrrole